- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 23 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.3: 2 residues within 4Å:- Chain A: N.43, R.416
Ligand excluded by PLIPSO4.4: 4 residues within 4Å:- Chain A: P.84, K.85, E.86, D.87
Ligand excluded by PLIPSO4.5: 2 residues within 4Å:- Chain A: K.73, R.499
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: T.155, R.163
Ligand excluded by PLIPSO4.12: 4 residues within 4Å:- Chain B: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain B: N.386, T.389, D.393
Ligand excluded by PLIPSO4.14: 3 residues within 4Å:- Chain B: N.43, D.53, R.416
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain B: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain B: K.73, R.499
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain B: T.155, R.163
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain C: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain C: V.150, T.155, R.163
Ligand excluded by PLIPSO4.27: 2 residues within 4Å:- Chain C: P.117, K.118
Ligand excluded by PLIPSO4.28: 2 residues within 4Å:- Chain C: K.73, R.499
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain C: N.43, D.53, R.416
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain C: Y.90, T.91
Ligand excluded by PLIPSO4.34: 2 residues within 4Å:- Chain D: K.202, T.203
Ligand excluded by PLIPSO4.35: 4 residues within 4Å:- Chain D: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.36: 2 residues within 4Å:- Chain D: P.117, K.118
Ligand excluded by PLIPSO4.37: 2 residues within 4Å:- Chain D: T.155, R.163
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain D: N.43, D.53, R.416
Ligand excluded by PLIP- 13 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.8: 3 residues within 4Å:- Chain A: W.446, N.474
- Chain C: E.497
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:N.474, A:N.474
- Water bridges: C:T.496
EDO.9: 6 residues within 4Å:- Chain A: V.98, A.107, P.108, F.109, F.161, Y.320
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:F.109
EDO.10: 3 residues within 4Å:- Chain A: R.306, D.408, E.409
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.409, A:E.409
EDO.18: 4 residues within 4Å:- Chain B: P.117, E.119
- Ligands: EDO.19, EDO.23
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.119
EDO.19: 2 residues within 4Å:- Ligands: EDO.18, EDO.23
No protein-ligand interaction detected (PLIP)EDO.20: 3 residues within 4Å:- Chain B: W.446, N.474
- Chain D: E.497
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain D- Hydrogen bonds: B:N.474, B:N.474
- Water bridges: D:T.496
EDO.21: 6 residues within 4Å:- Chain B: G.65, H.66, V.67, W.318, R.330
- Ligands: FDA.11
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:V.67
- Water bridges: B:T.332
EDO.22: 2 residues within 4Å:- Chain B: M.162, N.166
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.166
EDO.23: 5 residues within 4Å:- Chain B: Q.101, E.119, E.120
- Ligands: EDO.18, EDO.19
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.119, B:E.120
EDO.31: 3 residues within 4Å:- Chain A: E.497
- Chain C: W.446, N.474
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:N.474, C:N.474
- Water bridges: A:T.496
EDO.32: 6 residues within 4Å:- Chain C: V.67, I.68, F.69, R.94, N.460
- Ligands: FDA.24
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.94, C:R.94, C:N.460
EDO.39: 3 residues within 4Å:- Chain B: E.497
- Chain D: W.446, N.474
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.474, D:N.474
EDO.40: 5 residues within 4Å:- Chain D: W.181, G.183, P.487, D.488, N.491
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:D.488, D:N.491
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Da Fonseca, I. et al., Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics. Biochemistry (2014)
- Release Date
- 2014-12-03
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 23 x SO4: SULFATE ION(Non-functional Binders)
- 13 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Da Fonseca, I. et al., Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics. Biochemistry (2014)
- Release Date
- 2014-12-03
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D